COMMUNIQUÉS West-GlobeNewswire

STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
26/02/2024
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations– HORSHAM, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- STRATA [...]
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
26/02/2024
CIRM Grant Awarded to Support Phase 1 Autoimmunity Study of FT819 CD19-targeted CAR T-cell Program for Systemic Lupus Erythematosus; Study Start-up Ongoing at Multiple Clinical Sites First Patient Treated in Phase 1 [...]
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
26/02/2024
SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
26/02/2024
Topline data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD) reported with promising results in secondary endpoints of overall severity and control of agitation/aggression Company [...]
Brain Canada launches Season 3 of Playing with Marbles podcast – inside youth mental health
26/02/2024
The Brain Canada – Vocal Fry production returns with Katie Jensen as host MONTREAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Playing with Marbles, Brain Canada’s English-language podcast on everything brain, is back. This [...]
La Fondation Brain Canada lance la saison 3 du balado Playing with Marbles - la santé mentale chez les jeunes
26/02/2024
La production de la Fondation Brain Canada et Vocal Fry, animée par Katie Jensen, est de retour MONTRÉAL, 26 févr. 2024 (GLOBE NEWSWIRE) -- Playing with Marbles, le balado anglais de la Fondation Brain Canada portant [...]
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS
26/02/2024
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS ISSUED A NOTICE OF NON-COMPLIANCE-WITHDRAWAL (NON/w) FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AB SCIENCE INTENDS TO SUBMIT A REQUEST FOR RECONSIDERATION [...]
AB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLA
26/02/2024
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A ÉMIS UN AVIS DE NON-CONFORMITÉ-RETRAIT (ANC-R) POUR LE MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE AB SCIENCE A L'INTENTION DE DÉPOSER UNE DEMANDE DE [...]
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
26/02/2024
The 2023 global medtech outsourcing market grew more than 11% to $81.5B, demonstrating strong market resilience FRAMINGHAM, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and [...]
BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)
26/02/2024
BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc’s Financial Statements Bulletin for January–December [...]
Aclarion Announces Pricing of $3.0 Million Public Offering
26/02/2024
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary [...]
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
26/02/2024
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Telesis Bio [...]
Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
26/02/2024
Uncle Bud's Reports Early Synergies and Measurable Performance Metrics in First Month Since PBIO Acquisition, Catapulting Company to Increased Heights in Market Presence and Consumer Engagement SOUTH EASTON, Mass., Feb [...]
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
26/02/2024
NGM Bio stockholders to receive $1.55 per share in cash, an 80% premium over the closing share price on the last trading day prior to disclosure of receipt from The Column Group of a non-binding expression of interest [...]
ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study
26/02/2024
neffy demonstrated statistically significant and clinically meaningful improvement in pruritus, hives, body surface area and erythema in treatment-resistant chronic spontaneous urticaria patients, a skin disorder that [...]
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
26/02/2024
AUSTIN, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 [...]
Healthcare Triangle Empowers Healthcare Providers to Harness AI and LLMs for Groundbreaking Outcomes
26/02/2024
Company’s latest initiative addresses growing demand for AI analytics to revolutionize patient care PLEASANTON, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” [...]
Nusano to Participate in the B. Riley Securities Radiopharma Investor Conference
26/02/2024
VALENCIA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced it will participate in a presentation and panel at the B. Riley [...]
Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met
26/02/2024
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]

Pages